Do I Qualify?
Carolina Aguilar's avatarPerson

Carolina Aguilar

CEO and Co-FounderINBRAIN Neuroelectronics

New York, NY

Member Since March 2022

Skills

Executive Leadership
Health Care Information Technology
Artificial Intelligence

About

I am a learner and a shaper, I like equally strategy and execution and believe on evolution through creativity and de-learning. I really get motivated by big challenges and like to execute in global environments. I believe in teams and the power of culture and collective thinking. People make companies and is the most important asset of all, a motivated team will conquer the world. I have more than 15 years of expertise in healthcare (Medical Devices in Neuromodulation, Diabetes & others) in addition to consumer goods experience. Love to cross-pollinate ideas between the scientific and FMCG worlds.I realised soon the brain is one of our most important organs, the one that keep us human and sane and thus I have dedicated most of my time to it. Attracted by brain interfaces I joined the world's biggest Medtech, Medtronic, to lead the most advanced neural interface program at that time in Deep Brain Stimulation (DBS). For 10 years in DBS I managed complex businesses in this field and a P&L of more than $140M together with large local and global teams that generated high single to double digit growth % YOY. In recent years I got involved in Value Based Healthcare where I drove the expansion of the first VBHC provider model in Diabetes for Medtronic signing a major deal in Saudi Arabia and winning the European VBHC prize in 2017 amongst other milestones. (Diabeter, a Harvard Business School Case). Having implemented and expanded successfully such a major program, I understood the importance of delivering solutions driven by the outcomes that matter to patients as a means to patient empowerment and healthcare sustainability. Having been for that long in the corporate side I decided it was time to make a key contribution to the speed of critical innovation and recently co-founded INBRAIN Neuroelectronics in the field of Bioelectronics with an incredible team coming from the nanoscience field, Medtronic and Philips. With VBHC principles, we are building the next generation of neural interfaces with graphene, the material that provided the Nobel Prize to Geim and Novoselov from Manchester University in 2010. Thus we are a spin-off from Graphene Flagship's partner the Nanoscience & Nanotechnology Institute of Catalonia (ICN2) using proprietary technology from the collaborative efforts between ICN2 , ICREA and Manchester University looking for a definite solution to nervous system related disorders. We are decoding brain and nerve signals into sustainable medical solutions! My motto is" The best way to predict the future is to create it" P. DruckerI’m a learner and a shaper, I like equally strategy and execution and believe on evolution through creativity and de-learning. I really get motivated by big challenges and like to execute in global environments. I believe in teams and the power of culture and collective thinking. People make companies and is the most important asset of all, a motivated team will conquer the world. I have more than 15 years of expertise in healthcare (Medical Devices in Neuromodulation, Diabetes & others) in addition to consumer goods experience. Love to cross-pollinate ideas between the scientific and FMCG worlds.I realised soon the brain is one of our most important organs, the one that keep us human and sane and thus I have dedicated most of my time to it. Attracted by brain interfaces I joined the world's biggest Medtech, Medtronic, to lead the most advanced neural interface program at that time in Deep Brain Stimulation (DBS). For 10 years in DBS I managed complex businesses in this field and a P&L of more than $140M together with large local and global teams that generated high single to double digit growth % YOY. In recent years I got involved in Value Based Healthcare where I drove the expansion of the first VBHC provider model in Diabetes for Medtronic signing a major deal in Saudi Arabia and winning the European VBHC prize in 2017 amongst other milestones. (Diabeter, a Harvard Business School Case). Having implemented and expanded successfully such a major program, I understood the importance of delivering solutions driven by the outcomes that matter to patients as a means to patient empowerment and healthcare sustainability. Having been for that long in the corporate side I decided it was time to make a key contribution to the speed of critical innovation and recently co-founded INBRAIN Neuroelectronics in the field of Bioelectronics with an incredible team coming from the nanoscience field, Medtronic and Philips. With VBHC principles, we are building the next generation of neural interfaces with graphene, the material that provided the Nobel Prize to Geim and Novoselov from Manchester University in 2010. Thus we are a spin-off from Graphene Flagship's partner the Nanoscience & Nanotechnology Institute of Catalonia (ICN2) using proprietary technology from the collaborative efforts between ICN2 , ICREA and Manchester University looking for a definite solution to nervous system related disorders. We are decoding brain and nerve signals into sustainable medical solutions! My motto is" The best way to predict the future is to create it" P. Drucker

Published content

17 business lessons from self-help and personal growth development 

expert panel

This is why working on yourself outside of the workplace can improve your ability to be a better manager who is more excited about the job. What does it take to become a better leader in the work world? You could ask 20 different people, but you'd quickly realize that the answer may vary depending on who you are talking to, and what circumstances in their life have shaped who they are today—personally and professionally. Here, 17 members of Fast Company Executive Board discuss what they learned when they blocked some time to focus on self-help improvement and personal growth development opportunities. They also weigh in on what their experience was like and how they applied it at the office. By pushing themselves beyond what's typically expected, these leaders have increased their ability to operate a more efficient and successful company as they continue to inspire their direct reports to do the same.

Company details

INBRAIN Neuroelectronics

Company bio

High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications

Industry

Technology

Area of focus

Personal Health
Neuroscience
Artificial Intelligence

Company size

51 - 200